Beihai Gofar Chuanshan Biological Co (SHSE:600538) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Beihai Gofar Chuanshan Biological Co EBITDA Margin % Related Terms
Beihai Gofar Chuanshan Biological Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beihai Gofar Chuanshan Biological Co EBITDA Margin % Chart
SHSE:600538 vs CTVA, CF: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, Beihai Gofar Chuanshan Biological Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beihai Gofar Chuanshan Biological Co EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Beihai Gofar Chuanshan Biological Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Beihai Gofar Chuanshan Biological Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beihai Gofar Chuanshan Biological Co (SHSE:600538) has a EBITDA Margin % of -7.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. According to the industry distribution chart, Beihai Gofar Chuanshan Biological Co ranks #236 out of 251 companies in the Agriculture industry, placing it in the top 94%.
Is Beihai Gofar Chuanshan Biological Co's EBITDA Margin % too high?
Beihai Gofar Chuanshan Biological Co's current EBITDA Margin % is -7.00%. Based on the distribution chart, Beihai Gofar Chuanshan Biological Co ranks #236 out of 251 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Beihai Gofar Chuanshan Biological Co has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Beihai Gofar Chuanshan Biological Co's EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Beihai Gofar Chuanshan Biological Co ranks #236 out of 251 companies for EBITDA Margin %. This places Beihai Gofar Chuanshan Biological Co in the lower half of its industry. The industry median EBITDA Margin % is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.60, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beihai Gofar Chuanshan Biological Co and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beihai Gofar Chuanshan Biological Co's current EBITDA Margin % is -7.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beihai Gofar Chuanshan Biological Co stock overvalued right now?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co (SHSE:600538) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.15, compared to a current price of ¥5.88 — trading 41.7% above its estimated fair value. The current EBITDA Margin % is -7.00%. Beihai Gofar Chuanshan Biological Co's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Beihai Gofar Chuanshan Biological Co (SHSE:600538), the current EBITDA Margin % is -7.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beihai Gofar Chuanshan Biological Co (SHSE:600538) Overvalued in 2026?
Based on GuruFocus' analysis, Beihai Gofar Chuanshan Biological Co stock appears to be overvalued.
The current stock price of ¥5.88 is trading 41.7% above its estimated GF Value™ of ¥4.15.
GuruFocus considers Beihai Gofar Chuanshan Biological Co to be Significantly Overvalued.
Key valuation signals for SHSE:600538:
EBITDA Margin %: -7.00%
GF Value™: ¥4.15 vs. price of ¥5.88 (41.7% above fair value)
No single metric tells the full story. See the SHSE:600538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beihai Gofar Chuanshan Biological Co Business Description
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
54GF Score
Get the complete analysis for SHSE:600538
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600538 has been successfully added to your 
